Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential

Current Protein and Peptide Science

Volumn 13, Issue 8, 2012, Pages 723-738

  Augustyniak, Daria ^a   Nowak, Judyta ^a   Lundy, Fionnuala T ^b  

^a UNIVERSITY OF WROC AW   (Poland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anti infective action; Antimicrobial action; Immunomodulation; Neuropeptides; Therapeutic potential

Indexed keywords

ALPHA INTERMEDIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; CALCITONIN GENE RELATED PEPTIDE; HISTATIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INDOLICIDIN; ISEGANAN; MAGAININ 2; NEUROPEPTIDE; NEUROTRANSMITTER; NUCLEAR FACTOR Y; OMIGANAN; PEXIGANAN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADAPTIVE IMMUNITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CELLULAR IMMUNITY; DRUG POTENTIATION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NERVOUS SYSTEM; NONHUMAN; PHAGOCYTOSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLEIOTROPY; REVIEW; SEPSIS; SURVIVAL; VIRUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; HUMANS; MICROBIAL SENSITIVITY TESTS; NEUROPEPTIDES;

EID: 84874857156     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920312804871139     Document Type: Review

References (179)

1. Hirsch, T.; Jacobsen, F.; Steinau, H.U.; Steinstraesser, L. Host defense peptides and the new line of defense against multiresistant infections. Protein Pept. Lett., 2008, 3, 238-243.
2. Hancock, R.E.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol., 2006, 24, 1551-1557.
3. Lundy, F.T.; O'Hare, M.M.T.; McKibben, B.M.; Fulton, C.R.; Briggs, J.E.; Linden, G.J. Radioimmunoassay quantification of adrenomedullin in human gingival crevicular fluid. Arch. Oral Biol., 2006, 51, 334-338.
4. Ader, R.; Cohen, D.; Felten, D.; Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet., 1995, 345, 99-103.
5. Brogden, K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol., 2005, 3, 238-250.
6. Shimizu, M.; Shigeri, Y.; Yoshikawa, S.; Yumoto, N. Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation. Antimicrob. Agents Chemother., 1998, 42, 2745-2746.
7. Cutuli, M.; Cristiani, S.; Lipton, J.M.; Catania, A. Antimicrobial effects of α-MSH peptides. J. Leukoc. Biol., 2000, 67, 233-239.
8. Allaker, R.P.; Zihni, C.; Kapas, S. An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol. Med. Microbiol., 1999, 23, 289-293.
9. Kowalska, K.; Carr, D.B.; Lipkowski, A.W. Direct antimicrobial properties of substance P. Life Sci., 2002, 71, 747-750.
10. Hansen, C.J.; Burnell, K.K.; Brogden, K.A. Antimicrobial activity of substance P and neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J. Neuroimmunol., 2006, 177, 215-218.
11. El Karim, I.A.; Linden, G.J.; Orr, D.F.; Lundy, F.T. Antimicrobial activity of neuropeptides against a range of microorganisms from skin, oral, respiratory and gastrointestinal tract sites. J. Neuroimmunol., 2008, 200, 11-16.
12. Holub, B.S.; Rauch, I.; Radner, S.; Sperl, W.; Hell, M.; Kofler, B. Effects of galanin message-associated peptide and neuropeptide Y against various non-albicans Candida strains. Int. J. Antimicrob. Agents, 2011, 38, 76-80.
13. Vouldoukis, I.; Shai, Y.; Nicolas, P.; Mor, A. Broad spectrum antibiotic activity of skin-PYY. FEBS Letters, 1996, 380, 237-240.
14. Gonzalez-Rey, E.; Chorny, A.; Delgado, M. VIP: an agent with license to kill infective parasites. Ann. NY Acad. Sci., 2006, 1070, 303-308.
15. Powers, J.P.; Hancock, R.E. The relationship between peptide structure and antibacterial activity. Peptides, 2003, 24, 1681-1691.
16. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415, 389-395.
17. Yeung, A.T.; Gellatly, S.L.; Hancock, R.E. Multifunctional cationic host defense peptides and their clinical applications. Cell Mol. Life Sci., 2011, 68, 2161-2176.
18. Madhuri, S.; Shireen, T.; Venugopal, S.K.; Ghosh, D.; Gadepalli, R.; Dhawan, B.; Mukhopadhyay, K. In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against human pathogen Staphylococcus aureus. Peptides, 2009, 30, 1627-1635.
19. Allaker, R.P.; Grosvenor, P.W.; McAnerney, D.C.; Sheehan, B.E.; Pell, K.; Kapas, S. Mechanisms of adrenomedullin antimicrobial action. Peptides, 2006, 27, 661-666.
20. Yang, D.; Chen, Q.; Hoover, D.M.; Staley, P.; Tucker, K.D.; Lubkowski, J.; Oppenhein, J.J. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J. Leuk. Biol., 2003, 74, 448-455.
21. Augustyniak, D.; Jankowski, A.; Mackiewicz, P.; Skowyra, A.; Gutowicz, J.; Drulis-Kawa, Z. Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Immunol., 2012, 13, 24.
22. Dathe, M.; Wieprecht, T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta, 1999, 1462, 71-87.
23. Peschel, A.; Sahl, H.G.; The coevolution of host cationic antimicrobial peptides and microbial resistance. Nature Rev. Microbiol., 2006, 4, 529-536.
24. Catania, A.; Colombo, G.; Rossi, C.; Carlin, A.; Sordi, A.; Lonati, C.; Turcatti, F.; Leonardi P.; Grieco, P.; Gatti, S. Antimicrobial properties of alpha-MSH and related synthetic melanocortins. ScientificWorldJournal, 2006, 6, 1241-1246.
25. Rauch, I.; Lundstrom, L.; Hell, M.; Sperl, W.; Kofler, B. Galanin message-associated peptide suppresses growth and the budded-tohyphal-form transition of Candida albicans. Antimicrob. Agents Chemother., 2007, 51, 4167-4170.
26. Villar, C.C.; Kashleva, H.; Dongari-Bagtzoglou, A. Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol. Immunol., 2004, 19, 262-269.
27. Wikberg, J.E.; Muceniece, R.; Mandrika, I.; Prusis, P.; Lindblom, J.; Post, C.; Skottner, A. New aspects on the melanocortins and their receptors. Pharmacol. Res., 2000, 42, 393-420.
28. Luque-Ortega, J.R.; Van't Hof, W.; Veerman, E.C.; Saugar, J.M.; Rivas, L. Human antimicrobial peptide histatin 5 is a cell penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J., 2008, 22, 1817-1828.
29. Delgado, M.; Anderson, P.; Garcia-Salcedo, J.A.; Caro, M.; Gonzalez-Rey, E. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death. Cell Death Differ., 2009, 16, 406-416.
30. Devine, D.A.; Marsh, P.D.; Percival, R.S.; Rangarajan, M.; Curtis, M.A. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology, 1999, 145, 965-971.
31. Allaker, R.P.; Sheehan, B.E.; McAnerney, D.C.; McKay I.J. Interaction of adrenomedullin and calcitonin gene-related peptide with the periodontal pathogen Porphyromonas gingivalis. FEMS Immunol. Med. Microbiol., 2007, 49, 91-97.
32. Madhuri, S.; Mukhopadhyay, K. C-terminal amino acids of alphamelanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus. Antimicrob. Agents Chemother., 2011, 55, 1920-1929.
33. Archer, N.K.; Mazaitis, M.J.; Costerton, J.W.; Leid, J.G.; Powers, M.E.; Shirtliff, M.E. Staphylococcus aureus biofilms. Properties, regulation and roles in human disease. Virulence, 2011, 2, 445-459.
34. Berger, A.; Tran, A.H.; Dedier, H.; Gardam, M.A.; Paige, Ch. J. Antimicrobial properties of hemokinin-1 against strains of Pseudomonas aeruginosa. Life Sci., 2009, 85, 700-703.
35. Joly, S.; Maze, C.; McCray, P.B.; Guthmiller, J.M. Human α-defensis 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol., 2004, 42, 1024-1029.
36. Nizet, V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol., 2006, 8, 11-26.
37. Harris, M.; Mora-Montes, H.M.; Gow, N.A.; Coote, P.J. Loss of mannosylophosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface. Microbiology, 2009,155, 1058-1070.
38. Lehrer, R.I.; Rosenman, M.; Harwig, S.S.; Jackson, R.; Eisenhauer, P. Ultrasensitive assay for endogenous antimicrobial polypeptides. J. Immunol. Methods. 1991, 137, 167-173.
39. Bowdish, D.M.; Davidson, D.J.; Hancock, R.E. A re-evaluation of the role of host defense peptides in mammalian immunity. Curr. Protein Pept. Sci., 2005, 6, 35-51.
40. Ohta, K.; Kajiya, M.; Zhou, T.; Nishi, H.; Mawardi, H.; Jane, S.; Elbadawi, L.; Kamata, N.; Komatsuzawa, H.; Kawai, T. Additive effects of Orexin B and vasointestinal polypeptide on LL-37-mediated antimicrobial activities. J. Neuroimmunol., 2011, 233, 37-45.
41. Sánchez-Gómez, S.; Lamata, M.; Leiva, J.; Blondelle, S.E.; Jerala, R.; Andrä, J.; Brandenburg, K.; Lohner, K.; Moriyón, I.; Martínezde-Tejada, G. Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides. BMC Microbiol., 2008, 8, 1-9.
42. Hökfelt, T.; Broberger, Ch.; Xu, Z-Q.D.; Sergeyev, V.; Ubink, R.; Diez, M. Neuropeptides -an overview. Neuropharmacology, 2000, 39, 1337-1356.
43. Bedoui, S.; Kromer, A.; Gebhardt, T.; Jacobs, R.; Raber, K.; Dimitrijevic, M.; Heine, J.; von Hörsten, S. Neuropeptide Y receptor-specifically modulates human neutrophil function. J. Neuroimmunol., 2008, 195, 88-95.
44. Wheway, J.; Mackay, C.R.; Newton, R.A.; Sainsburg, A.; Boey, D.; Herzog, H.; Mackay, F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. JEM, 2005, 202, 1527-1538.
45. Underhill, D.M.; Ozinsky, A. Phagocytosis of microbes: complexity in action. Ann. Rev. Immunol., 2002, 20, 825-852.
46. Ferreira, R.; Santos, T.; Viegas, M.; Cortes, L.; Barnardino, L.; Vieira, O.V.; Malva, J.O. Neuropeptide Y inhibits interleukin-1α-induced phagocytosis by microglial cells. J. Neuroinflammation, 2011, 8, 169-184.
47. Ahmed, A.A.; Wahbi, A.; Nordlind, K.; Kharazmi, A.; Sundqvist, K-G.; Mutt, V.; Lidén, S. In vitro Leischmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand. J. Immunol., 1998, 48, 79-85.
48. Ahmed, A.A.; Wahbi, A.H.; Nordlin, K. Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol. Immnotoxicol., 2001, 23, 397-409.
49. Gregory, D.J.; Olivier, M. Subversion of host cell signaling by the protozoan parasite Leishmania. Parasitology, 2005, 130, 27-35.
50. De la Fuente, M.; Bernaez, I.; Del Rio, M.; Hernanz, A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology, 1993, 80, 259-265.
51. Ichinose, M.; Sawada, M. Enhancement of phagocytosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Peptides, 1996, 17, 1405-1414.
52. Bondesson, L.; Nordlind, K.; Lidén, S.; Gafvelin, G.; Theodorsson, E.; Mutt, V. Dual effects of vasointestinal polypeptide (VIP) on leukocyte migration. Acta Physiol. Scand., 1991, 141, 477-481.
53. Cuesta, M.C.; Quintero, L.; Pons, H.; Suarez-Roca, H. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem. Int., 2002, 40, 301-306.
54. Yaraee, R.; Ghazanfari, T. Substance P potentiates TGF-α1 production in lung epithelial cell lines. Iran J. Allergy Asthma Immunol., 2009, 8, 19-24.
55. Gallicchio, M.; Benetti, E.; Rosa, A.C.; Fantozzi, R. Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes. British J. Pharmacol., 2009, 156, 486-496.
56. Lorenz, D.; Wiesner, B.; Zipper, J.; Winkler, A.; Krause, E.; Beyermann, M.; Lindau, M.; Bienert, M. Mechanism of peptideinduced mast cell degranulation. Translocation and patch-clamp studies. J. Gen. Physiol., 1998, 112, 577-591.
57. Kulka, M.; Sheen, C.H.; Tancowny, B.P.; Grammer, L.C.; Schleimer, R.P. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology, 2008, 123, 398-410.
58. Foster, N.; Cheetham, J.; Tylor, J.J.; Preshaw, P.M. VIP inhibits Porphyromonas gingivalis LPS-induced immune responses in human monocytes. J. Dent. Res., 2005, 84, 999-1004.
59. Gonzalez-Rey, E.; Chorny, A.; Delgado, M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol., 2007, 7, 52-63.
60. Luger, T.A.; Scholzen T.E.; Brzoska T.; Böhm, M. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. NY. Acad. Sci., 2003, 994, 133-140.
61. Kubo, A.; Minamino, N.; Isumi, Y.; Katafuchi, T.; Kangawa, K.; Dohi, K.; Matsuo, H. Production of adrenomedullin in macrophage cell line and peritoneal macrophages. J. Biol. Chem., 1998, 273, 16730-16738.
62. Wong, L.Y.; Cheung, B.M.; Li, Y.Y.; Tang, F. Adrenomedullin is both proinflammatory and anti-inflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology, 2005, 146, 1321-1327.
63. Wu, R.; Zhou, M.; Wang, P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept., 2003, 112, 19-26.
64. Miksa, M.; Wu, R.; Cui, X.; Dong, W.; Das, P.; Simms, H.H.; Ravikumar, T.S.; Wang, P. Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma. J. Immunol., 2007, 179, 6263-6272.
65. Killough, S.A.; Lundy, F.T.; Irwin, C.R. Dental pulp fibroblasts express neuropeptide Y Y1 receptor but not neuropeptide Y. Int. Endod. J., 2010, 43, 835-842.
66. El Karim, I.A.; Lamey, P.J., Linden, G.J.; Lundy, F.T. Neuropeptide Y Y1 receptor in human dental pulp cells of noncarious and carious teeth. Int. Endod. J., 2008, 41, 850-855.
67. Killough, S.A.; Lundy, F.T.; Irwin, C.R. Substance P expression by human dental pulp fibroblasts: a potential role in neurogenic inflammation. J. Endod., 2009, 35, 73-77.
68. Kuo, H.P.; Lin, H.Ch.; Hwang K.H.; Wang, Ch.H.; Lu, L.Ch. Lipopolysaccharide enhances substance P-mediated neutrophil adherence to epithelial cells and cytokine release. Am. J. Respir. Crit. Care Med., 2000, 162, 1891-1897.
69. Brogden, K.A.; Guthmiller, J.M.; Salzet, M.; Zasloff, M. The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol., 2005, 6, 558-564
70. Lee, H.Y.; Andalibi, A.; Webster, P.; Moon, S.K.; Teufert, K.; Kang, S.H.; Li, J.D. Nagura, M.; Ganz, T.; Lim, D.J. Antimicrobial activity of innate immune molecules against Streptococcus pneumonia, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect. Dis., 2004, 4, 1-12.
71. Pio, R.; Martinez, A.; Unsworth, E.J.; Kowalak, J.A.; Bengoechea, J.A.; Zipfel, P.F.; Elsasser, T.H.; Cuttitta, F. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J. Biol. Chem., 2001, 276, 12292-12300.
72. Zudaire, E.; Portal-Nunez, S.; Cuttitta, F. The central role of adrenomedullin in host defense. J. Leukoc. Biol., 2006, 80, 237-244.
73. Zudaire, E.; Martínez, A.; Garayoa, M.; Pío, R.; Kaur, G.; Woolhiser, M.R.; Metcalfe, D.D.; Hook, W.A.; Siraganian, R.P.; Guise, T.A.; Chirgwin, J.M.; Cuttitta, F. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am. J. Pathol., 2006, 168, 280-291.
74. Harzenetter, M.D.; Keller, U.; Beer, S.; Riedl, C.; Peschel, Ch.; Holzmann, B. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp. Hematol., 2002, 30, 306-312.
75. Richter, J.; Andersson, R.; Edvinsson, L.; Gullberg, U. Calcitonin gene-related peptide (CGRP) activates human neutrophils -inhibition by chemotactic peptide antagonist BOC-MLP. Immunology, 1992, 77, 416-421.
76. Levite, M. Neuropeptides by direct interaction with T cells induce cytokine secretion and break the commitment to a distinct T helper phenotype. PNAS, 1998, 95, 12544-12549.
77. Dunzendorfer, S.; Kaser, A.; Meierhofer, C.; Tilg, H.; Wiedermann, C.J. Peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J. Immunol., 2001, 166, 2167-2172.
78. Loser, K.; Brzoska, T.; Oji, V.; Auriemma, M.; Voskort, M.; Kupas, V.; Klenner, L.; Mensing, C.; Hauschild, A.; Beissert, S.; Luger, T.A. The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans. PLoS ONE, 2010, 5, 1-12.
79. Bisgaard, H.; Hermansen, M.N.; Buchvald, F.; Loland, L.; Halkjaer, L.B.; Bønnelykke, K.; Brasholt, M.; Heltberg, A.; Vissing, N.H.; Thorsen, S.V.; Stage, M.; Pipper, C.B. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med., 2007, 357, 1487-1495.
80. Patel, I.; Seemungal, T.; Wilks, M.; Lloyd-Owen, S.; Donaldson, G.; Wedzicha, J. Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax, 2002, 57, 759-764.
81. Levite, M.; Cahalon, L.; Hershkowiz, R.; Steinman, L.; Lider, O. Neuropeptides via specific receptors regulate T cell adhesion to fibronectin. J. Immunol., 1998, 160, 993-1000.
82. Augustyniak, D.; Majkowska-Skrobek, G.; Basiewicz-Worsztynowicz, B.; Jankowski, A. The role of IL-6/sIL-6R complex and its natural inhibitor sgp 130 in modulation of inflammatory process. Post. Biochem., 2006, 52, 194-203.
83. Braun, A.; Wiebe, P.; Pfeufer, A.; Gessner, R.; Renz, H. Differential modulation of human immunoglobulin isotype production by the neuropeptides substance P, NKA and NKB. J. Neuroimmunol., 1999, 97, 43-50.
84. Stanisz, A.M.; Befus, D.; Bienenstock, J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesentheric lymph nodes, and spleen. J. Immunol., 1986, 136, 152-156.
85. Lundy, F.T.; Nelson, J.; Lockhart, D.; Greer, B.; Harriott, P.; Marley, J.J. Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges. Mol. Immunol., 2008, 45, 190-193.
86. Fjell, Ch.D.; Hiss, J.A.; Hancock, R.E.W.; Schneider, G. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov., 2011, 11, 37-51.
87. Gordon, Y.J.; Romanowski, E.G. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res., 2005, 30, 505-515.
88. Varela, N.; Chorny, A.; Gonzalez-Rey, E.; Delgado, M. Tuning inflammation with anti-inflammatory neuropeptides. Expert Opin. Biol. Ther., 2007, 7, 461-478.
89. Gonzalez-Rey, E.; Delgado-Maroto, V.; Souza Moreira, L.; Delgado, M. Neuropeptides as therapeutic approach to autoimmune diseases. Curr. Pharm. Des., 2010, 16, 3158-3172.
90. Silva, O.N.; Mulder, K.C.; Barbosa, A.E.; Otero-Gonzalez, A.J.; Lopez-Abarrategui, C.L.; Rezende, T.M.; Dias, S.C.; Franco, O.L. Exploring the pharmacological potential of promiscuous hostdefense peptides: from natural screenings to biotechnological applications. Frontiers Microbiol., 2011, 2, 1-14.
91. Inaba, Y.; Ashida, T.; Ito, T.; Ishikawa, C.; Tanabe, H.; Maemoto, A.; Watari, J.; Ayabe, T.; Mizukami, Y.; Fujiya, M.; Kohgo, Y. Expression of the antimicrobial peptide alpha-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice. Inflamm. Bowel Dis., 2010, 16, 1488-1495.
92. Bernard, J.J.; Gallo, R.L. Protecting the boundary: the sentinel role of host defense peptides in the skin. Cell Mol. Life Sci., 2011, 68, 2189-2199.
93. Lundy, F.T.; El Karim, I.A.; Linden, G.J. Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease. Arch. Oral Biol., 2009, 54, 258-262.
94. Zhang, H.; Yan, Y.; Shi, R.; Lin, Z.; Wang, M.; Lin, L. Correlation of gut hormones with irritable bowel syndrome. Digestion, 2008, 78, 72-76.
95. Türkoǧlu, O.; Emingil, G.; Kütükçüler, N.; Atilla, G. Evaluation of gingival crevicular fluid adrenomedullin and human neutrophil peptide 1-3 levels of patients with different periodontal diseases. J. Periodontol., 2010, 81, 284-291.
96. Lucchese, A.; Guida, A.; Petruzzi, M.; Capone, G.; Laino, L.; Serpico, R. Peptides in oral diseases. Curr. Pharm. Des., 2012, 18, 782-788.
97. Grissell, T.V.; Chang, A.B.; Gibson, P.G. Reduced Toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonization in children. Pediatric Pulmunol., 2007, 42, 380-385.
98. Lighvani, S.; Huang, X.; Trivedi, P.P.; Swanborg, R.H.; Hazlett, L.D. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection. Eur. J. Immunol., 2005, 35, 1567-1575.
99. Allaker, R.P.; Kapas, S. Adrenomedullin expression by gastric epithelial cells in response to infection. Clin. Diagn. Lab. Immunol., 2003, 10, 546-551.
100. Brell, B.; Temmesfeld-Wollbrück, B.; Altzschner, I.; Frisch, E.; Schmeck, B.; Hocke, A.C.; Suttorp, N.; Hippenstiel, S. Adrenomedullin reduces Staphylococcus aureus alpha-toxin-induced rat ileum microcirculatory damage. Crit. Care Med., 2005, 88, 819-826.
101. Temmesfeld-Wollbrück, B.; Brell, B.; Dohna, C.; Dorenberg, M.; Hocke, A.C.; Martens, H.; Klar, J.; Suttorp, N.; Hippenstiel, S. Adrenomedullin reduces intestinal epithelial permeability in vivo and in vitro. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297, 43-51.
102. Fink, M.P. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr. Opin. Crit. Care, 2003, 9, 143-151.
103. Donnarumma, G.; Paoletti, I.; Buommino, E.; Tufano, M.A.; Baroni, A. Alpha-MSH reduces the internalization of Staphylococcus aureus and down-regulates HSP 70, integrins and cytokine expression in human keratinocyte cell lines. Exp. Dermatol., 2004, 13, 748-754.
104. Ozmen, L.; Pericin, M.; Hakimi, J.; Chizzonite, R.A.; Wysocka, M.; Trinchieri, G.; Gately, M.; Garotta, G. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med., 1994, 180, 907-915.
105. Delgado Hernàndez, R.; Demitri, M.T.; Carlin, A.; Meazza, C.; Villa, P.; Ghezzi, P.; Lipton, J.M.; Catania, A. Inhibition of systemic inflammation by central action of the neuropeptide alphamelanocyte-stimulating hormone. Neuroimmunomodulation, 1999, 6, 187-92.
106. Doi, K.; Hu, X.; Yuen, P.; Leelahavanichkul, A.; Yasuda, H.; Kim, S.M.; Schnermann, J.: Jonassen, T.; Frøkiær, J.; Nielsen, S.; Star, R. AP214, an analogue of α-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int., 2008, 73, 1266-1274.
107. Delgado, M.; Martinez, C.; Pozo, D.; Calvo, J.R.; Leceta, J. et al. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal en dotoxemia through the inhibition of TNF-alpha and IL-6. J. Immunol., 1999, 162, 1200-1205.
108. Delgado, M.; Pozo, D.; Ganea, D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol. Rev., 2004, 56, 249-290.
109. Chorny, A.; Delgado, M. Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1. Am. J. Pathol., 2008, 172, 1297-1307.
110. Abad, C.; Tan, Y.V.; Cheung-Lau, G.; Nobuta, H.; Waschek, J.A. VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses. PLoS One, 2012, 7, Epub 2012
111. Chorny, A.; Anderson, P.; Gonzalez-Rey, E.; Delgado, M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J. Immunol., 2008, 180, 8369-8377.
112. Gonzalez-Rey, E.; Chorny, A.; Varela, N.; Robledo, G.; Delgado, M. Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am. J. Pathol., 2006, 168, 1921-1930.
113. Temmesfeld-Wollbrück, B.; Brell, B.; David, I.; Dorenberg, M.; Adolphs, J.; Schmeck, B.; Suttorp, N.; Hippenstiel, S. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Med., 2007, 33, 703-710.
114. Felies, M.; Von Hörsten, S.; Pabst, R.; Nave, H. Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxemic rats. J. Physiol., 2004, 561, 245-252.
115. Du, M.; Butchi, N.B.; Woods, T.; Morgan, T.W.; Peterson, K.E. Neuropeptide Y has a protective role during murine retrovirusinduced neurological disease. J. Virol., 2010, 84, 11076-11088.
116. Makhortova, N.R.; Askovich, P.; Patterson, C.E.; Gechman, L.A.; Gerard, N.P.; Rall, G.F. Neurokinin-1 enables measles virus transsynaptic spread in neureons. Virology, 2007, 362, 235-244.
117. Yaraee, R.; Ebtekar, M.; Ahmadiani, A.; Sabahi, F. Neuropeptides (SP and CGRP) augment pro-inflammatory cytokine production in HSV-infected macrophages. Int. Immunopharmacol., 2003, 3, 1883-1887.
118. Dakhama, A.; Park, J.W.; Taube, Ch.; El Gazzar, M.; Kodama, T.; Miyahara, N.; Takeda, K.; Kanehiro, A.; Balhorn, A.; Joetham, A.; Loader, J.E.; Larsen G.L; Gelfand, E.W. Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am. J. Physiol. Lung Cell. Mol. Physiol., 2005, 288, 761-770.
119. Ho, W.Z.; Cnaan, A.; Li, Y.H.; Zhao, H.; Lee, H.R.; Song, L.; Douglas S.D. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res. Hum. Retroviruses, 1996, 12, 195-198.
120. Li, Y.; Douglas, S.D.; Song, L.; Sun, S.; Ho, W.Z. Substance P enhances HIV-1 replication in latently infected human immune cells. J. Neuroimmunol., 2001, 121, 67-75.
121. Wang, X.; Douglas, S.D.; Lai, J.P.; Tuluc, F.; Tebas, P.; Ho, W.Z. Neurokinin-1 receptor antagonist (aprepitant) inhibits drugresistant HIV-1 infection of macrophages in vitro. J. Neuroimmune Pharmacol., 2007, 2, 42-48.
122. Branch, D.R. Neuropeptide receptors: Novel targets for HIV/AIDS therapeutics. Pharmaceuticals, 2011, 4, 485-493.
123. Lundy, F.T.; Linden, G.J. Neuropeptides and neurogenic mechanisms in oral and periodontal inflammation. Crit. Rev. Oral Biol. Med., 2004, 15, 82-98.
124. Charnley, M.; Moir, A.J.; Douglas, C.W.; Haycock, J.W. Antimicrobial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gramnegative bacteria. Peptides, 2008, 29, 1004-1009.
125. Rauch, I.; Holzmeister, S.; Kofler, B. Anti-Candida activity of α-melanocyte-stimulating hormone (α-MSH) peptides. J. Leukoc. Biol., 2009, 85, 371-372.
126. Wozniak, A.; McLennan, G.; Betts, W.H.; Murphy, G.A.; Scicchitano, R. Activation of human neutrophils by substance P: effect on FMLP stimulated oxidative and arachidonic acid metabolism and on antibody-dependent cell-mediated cytotoxicity. Immunology, 1989, 68, 359-364.
127. Harfi, I.; Corazza, F.; D'Hondt, S.; Sariban, E. Differential calcium regulation of proinflammatory activities in human neutrophils exposed to the neuropeptide pituitary adenylate cyclase-activating protein. J. Immunol., 2005, 175, 4091-4102.
128. Catania, A.; Rajora, N.; Capsoni, F.; Minonzio, F.; Star, R.A.; Lipton, J.M. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides, 1996, 17, 675-9.
129. Nave, H.; Bedoui, S.; Moenter, F.; Steffens, J.; Felies, M.; Gebhardt, T.; Straub, R.H.; Pabst, R.; Dimitrijevic, M.; Stanojevic, S.; von Hörsten, S. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J. Neuroimmunol., 2004, 155, 1-12.
130. Ho, W.Z.; Lai, J.P.; Zhu, X.H.; Uvaydova, M.; Douglas, S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol., 1997, 159, 5654-5660.
131. Delgado, M.; Ganea, D. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain Behav. Immun., 2008, 22, 1146-1151.
132. Lara-Marquez, M.L.; O'Dorisio, M.S.; O'Dorisio, T.M.; Shah, M.H.; Karacay, B. Selective gene expression and activationdependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J. Immunol., 2001, 166, 2522-2530.
133. Delgado, M.; Ganea, D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor κBdependent gene activation at multiple levels in the human monocytic cell line THP-1. J. Biol. Chem., 2001, 276, 369-380.
134. Dewit, D.; Gourlet, P.; Amraoui, Z.; Vertongen, P.; Willems, F.; Robberetch, P.; Goldman, M. The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes. Immunol. Lett., 1998, 60, 57-60.
135. Bhardwaj, R.; Becher, E.; Mahnke, K.; Hartmeyer, M.; Schwarz, T.; Scholzen, T.; Luger, T.A. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J. Immunol., 1997, 158, 3378-3384.
136. Rajora, N.; Ceriani, G.; Catania, A.; Star, R.A.; Murphy, M.T.; Lipton, J.M. Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukoc. Biol., 1996, 59, 248-53.
137. Taherzadeh, S.; Sharma, S.; Chhajlani, V.; Gantz, I.; Rajora, N.; Demitri, M.T.; Kelly, L.; Zhao, H.; Ichiyama, T.; Catania, A.; Lipton, J.M. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/ macrophages. Am. J. Physiol., 1999, 276, 1289-1294.
138. Prod'homme, T.; Weber, M.S.; Steinman, L.; Zamvil, S.S. A neuropeptide in immune-mediated inflammation, Y? Trends Immunol., 2006, 27, 164-167.
139. Vignery, A.; Wang, F.; Ganz, M.B. Macrophages express functional receptors for calcitonin-gene related peptide. J. Cell Physiol., 1991, 149, 301-306.
140. Delgado, M.; Pozo, D.; Martinez, C.; Garrido, E.; Leceta, J.; Calvo, J.R.; Gomariz, R.P. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages. Regul. Pept., 1996, 62, 161-166.
141. Delgado, M.; Munoz-Elias, E.J.; Gomariz, R.P.; Ganea, D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages: subsequent effect on IFN synthesis by T cells. J. Neuroimmunol., 1999, 96, 167-181.
142. Groneberg, D.A.; Hartmann, P.; Dinh, Q.T.; Fischer, A. Expression and distribution of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human airways. Lab. Invest., 2001, 81, 749-755.
143. Pozo, D.; Delgado, M.; Martinez, C.; Gomariz, R.P.; Guerrero, J.M.; Calvo, J.R. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim. Biophys. Acta, 1997, 1359, 250-262.
144. Star, R.A.; Rajora, N.; Huang, J.; Stock, R.C.; Catania, A.; Lipton, J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci., 1995, 92, 8016-8020.
145. Neumann Andersen, G.; Nagaeva, O.; Mandrika, I.; Petrovska, R.; Muceniece, R.; Mincheva-Nilsson, L.; Wikberg, J.E. MC(1) receptors are constitutively expressed on leukocyte subpopulations with antigen presenting and cytotoxic functions. Clin. Exp. Immunol., 2001, 126, 441-446.
146. Bost, K.L.; Pascual, D.W. Substance P: a late-acting B lymphocyte differentiation cofactor. Am. J. Physiol., 1992, 262, 537-545.
147. Lai, J.; Douglas, S.D.; Ho, W. Human lymphocytes express substance P and its receptor. J. Neuroimmunol., 1998, 86, 80-86.
148. Lambrecht, B.N. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res., 2001, 2, 133-138.
149. O'Connor, T.M.; O'Connell, J.; O'Brien, D.I. The role of substance P in inflammatory disease. J. Cell Physiol., 2004, 201, 167-80.
150. Okada, T.; Hirayama, Y.; Kishi, S.; Miyayasu, K.; Hiroi, J.; Fujii, T. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells. Inflamm. Res., 1999, 48, 274-279.
151. Groneberg, D.A.; Welker, P.; Fischer, T.C.; Dinh, Q.T.; Grutzkau, A.; Peiser, C.; Wahn, U.; Henz, B.M.; Fischer, A. Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J. Allergy Clin. Immunol., 2003, 111, 1099-1105.
152. Adachi, S.; Nakano, T.; Vliagoftis, H.; Metcalfe, D.D. Receptormediated modulation of murine mast cell function by alphamelanocyte stimulating hormone. J. Immunol., 1999, 163, 3363-3368.
153. Marriott, I.; Bost, K.L. Expression of authentic substance P receptors in murine and human dendritic cells. J. Neuroimmunol., 2001, 114, 131-41.
154. Carruci, J.A.; Agnatius, R.; Wei, Y.; Cypess, A.M.; Schaer, D.A.; Pope, M.; Steinman, R.M.; Mojsov, S. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T-cell proliferative responses via the type I calcitonin gene-related peptide receptor. J. Immunol., 2000, 164, 3494-3499.
155. Becher, E.; Mahnke, K.; Brzoska, T.; Kalden, DH.; Grabbe, S.; Luger, T.A. Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann. NY Acad. Sci., 1999, 885, 188-95.
156. Feistritzer, C.; Clausen, J.; Sturn, D.H.; Djanani, A.; Gunsilius, E.; Wiedermann, C.J.; Kahler, C.M. Natural killer cell functions mediated by the neuropeptide substance P. Regul. Pept., 2003, 116, 119-126.
157. Liu, J.Y.; Hu, J.H.; Zhu, Q.G.; Li, F.Q.; Sun, H.J. Substance P receptor expression in human skin keratinocytes and fibroblasts. Br. J. Dermatol., 2006, 155, 657-662.
158. Albertin, G.; Carraro, G.; Parnigotto, P.P.; Conconi, M.T.; Ziolkowska, A.; Malendowicz, L.K. Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int. J. Mol. Med., 2003, 11, 635-639.
159. Granoth, R.; Fridkin, M.; Gozes, I. VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes. FEBS Lett., 2000, 475, 78-83.
160. Kakurai, M.; Fujita, N.; Murata, S.; Furukawa, Y.; Demitsu, T.; Nakagawa, H. Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J. Investig. Dermatol., 2001, 116, 743-749.
161. Schwarz, H.; Villiger, P.M.; von Kempis, J.; Lotz, M. Neuropeptide Y is an inducible gene in the human immune system. J. Neuroimmunol., 1994, 51, 53-61.
162. Bracci-Laudiero, L.; Aloe, L.; Caroleo, MC.; Buanne, P.; Costa, N.; Starace, G.; Lundeberg, T. Endogenous NGF regulates CGRP expression in human monocytes and affects HLADR B7 expression and IL-10 production. Blood, 2005, 106, 3507-3514.
163. Nakayama, M.; Takahashi, K.; Murakami, O.; Murakami, H.; Sasano, H.; Shirato, K.; Shibahara, S. Adrenomedullin in monocytes and macrophages: possible involvement of macrophagederived adrenomedullin in atherogenesis. Clin. Sci. (Lond.), 1999, 97, 247-251.
164. Aliakbari, J.; Sreedharan, S.P.; Turck, C.W.; Goetzl, EJ. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem. Biophys. Res. Commun., 1987, 148, 1440-1445.
165. O'Dorisio, M.S.; O'Dorisio, T.M.; Cataland, S.; Balcerzak, S.P. Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J. Lab. Clin. Med., 1980, 96, 666-672.
166. McLachlan, J. L.; Smith, A. J.; Bujalska, I. J.; Cooper, P. R. Gene expression profiling of pulpal tissue reveals the molecular complexity of dental caries. Biochim. Biophys. Acta, 2005, 1741, 271-281.
167. Bracci-Laudiero, L.; Aloe, L.; Buanne, P.; Finn, A.; Stenfors, C.; Vigneti, E.; Theodorsson, E.; Lundeberg, T. NGF modulates CGRP synthesis in human B-lymphocytes: a possible antiinflammatory action of NGF? J. Neuroimmunol., 2002, 123, 58-65.
168. Zudaire, E.; Martínez, A.; Garayoa, M.; Pío, R.; Kaur, G.; Woolhiser, M.R.; Metcalfe, D.D.; Hook, W.A.; Siraganian, R.P.; Guise, T.A.; Chirgwin, J.M.; Cuttitta F. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am. J. Pathol., 2006, 168, 280-91.
169. Lambert, R.W.; Campton, K.; Ding, W.; Ozawa, H.; Granstein, R.D. Langerhans cell expression of neuropeptide Y and peptide YY. Neuropeptides, 2002, 36, 246-251.
170. Lambrecht, B.N.; Germonpre, P.R.; Everaert, E.G.; Carro-Muino, I.; De Veerman, M.; De Felipe, C.; Hunt, S.P.; Thielemans, K.; Joos, G.F.; Pauwels, R.A. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur. J. Immunol., 1999, 29, 3815-3825.
171. He, Y.; Ding, G.; Wang, X.; Zhu, T.; Fan, S. Calcitonin generelated peptide in Langerhans cells in psoriatic plaque lesions. Chin. Med. J. (Engl)., 2000, 113, 747-751.
172. Sun, J.; Ramnath, R.D.; Bhatia, M. Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils. Am. J. Physiol. Cell Physiol., 2007, 293, 696-704.
173. Kaneider, N.C.; Egger, P.; Djanani, A.M.; Wiedermann, Ch.J. Leukocyte motility in response to neuropeptides is heperan sulfate proteoglycan dependent. Peptides, 2003, 24, 695-700.
174. Sterner-Kock, A.; Braun, R.K.; Van der Vliet, A.; Schrenzel, M.D.; McDonald, R.J.; Kabbur, M.B.; Vulliet, P.R.; Hyde, D.M. Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils. J. Leukoc. Biol., 1999, 65, 834-840.
175. El-Shazly, A.E.; Masuyama, K.; Ishikawa, T. Mechanisms involved in activation of human eosinophil exocytosis by substance P: an in vitro model of sensory neuroimmunomodulation. Immunol. Invest., 1997, 26, 615-629.
176. Li, W.; Wang, T.; Ma, Ch.; Xiong, T.; Zhu, Y.; Wang, X. Calcitonin gene-related peptide inhibits interleukin 1-α-induced enogenous monocyte chemoattractant protein-1 secretion in type II alveolar epithelial cells. Am. J. Physiol. Cell Physiol., 2006, 291, 456-465.
177. Souza-Moreira, L.; Campos-Salinas, J.; Caro, M.; Gonzalez-Rey, E. Neuropeptides as pleiotropic modulators of the immune response. Neuroendocrinology, 2011, 94, 89-100.
178. Delgado, M.; Gonzalez-Rey, E.; Ganea, D. The neuropeptide vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. J. Leukoc. Biol., 2005, 78, 1327-1338.
179. Sternberg, E.M.; Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol., 2006, 6, 318-328.